Literature DB >> 12966493

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.

Robert E Marx.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12966493     DOI： 10.1016/s0278-2391(03)00720-1

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN： 0278-2391            Impact factor:   1.895


× No keyword cloud information.
  567 in total

1.  Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws.

Authors:  Thomas Mücke; Janett Koschinski; Herbert Deppe; Stefan Wagenpfeil; Christoph Pautke; David A Mitchell; Klaus-Dietrich Wolff; Frank Hölzle
Journal:  J Cancer Res Clin Oncol       Date:  2010-10-07       Impact factor: 4.553

2.  Drug holiday as a prognostic factor of medication-related osteonecrosis of the jaw.

Authors:  Yoon Ho Kim; Ho Kyung Lee; Seung Il Song; Jeong Keun Lee
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2014-10-24

3.  Low-level laser therapy supported teeth extractions of two patients receiving IV zolendronate.

Authors:  Bahadir Kan; Mehmet Ali Altay; Ferda Taşar; Murat Akova
Journal:  Lasers Med Sci       Date:  2010-07-29       Impact factor: 3.161

Review 4.  A systematic review of bisphosphonate osteonecrosis (BON) in cancer.

Authors:  Cesar Augusto Migliorati; Sook-Bin Woo; Ian Hewson; Andrei Barasch; Linda S Elting; Fred K L Spijkervet; Michael T Brennan
Journal:  Support Care Cancer       Date:  2010-04-22       Impact factor: 3.603

Review 5.  Osteonecrosis of the jaw induced by clodronate, an alkylbiphosphonate: case report and literature review.

Authors:  Sabrina Crépin; Marie-Laure Laroche; Bernard Sarry; Louis Merle
Journal:  Eur J Clin Pharmacol       Date:  2010-05-01       Impact factor: 2.953

6.  Osteonecrosis of the jaw in older osteoporosis patients treated with intravenous bisphosphonates.

Authors:  Jacques Baillargeon; Yong Fang Kuo; Yu-Li Lin; Gregg S Wilkinson; James S Goodwin
Journal:  Ann Pharmacother       Date:  2011-09-27       Impact factor: 3.154

7.  Osteomalacia: the missing link in the pathogenesis of bisphosphonate-related osteonecrosis of the jaws?

Authors:  Alberto Bedogni; Giorgia Saia; Giordana Bettini; Anita Tronchet; Andrea Totola; Giorgio Bedogni; Paolo Tregnago; Maria Teresa Valenti; Francesco Bertoldo; Giuseppe Ferronato; Pier Francesco Nocini; Stella Blandamura; Luca Dalle Carbonare
Journal:  Oncologist       Date:  2012-06-20

8.  Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.

Authors:  Jeanny B Aragon-Ching; Yang-Min Ning; Clara C Chen; Lea Latham; Jean-Pierre Guadagnini; James L Gulley; Philip M Arlen; John J Wright; Howard Parnes; William D Figg; William L Dahut
Journal:  Cancer Invest       Date:  2009-02       Impact factor: 2.176

Review 9.  Pathologic fractures in bisphosphonate-related osteonecrosis of the jaw-review of the literature and review of our own cases.

Authors:  Sven Otto; Christoph Pautke; Sigurd Hafner; Ronny Hesse; Lea Franziska Reichardt; Gerson Mast; Michael Ehrenfeld; Carl-Peter Cornelius
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2013-05-31

10.  Use of Ultrasonic Bone Surgery (Piezosurgery) to Surgically Treat Bisphosphonate-Related Osteonecrosis of the Jaws (BRONJ). A Case Series Report with at Least 1 Year of Follow-Up.

Authors:  Cornelio Blus; Serge Szmukler-Moncler; Giulio Giannelli; Gloria Denotti; Germano Orrù
Journal:  Open Dent J       Date:  2013-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.